Rockefeller Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378 Sell
27
-13
-33% -$175 ﹤0.01% 4579
2025
Q4
$449 Buy
40
+14
+54% +$160 ﹤0.01% 4539
2025
Q3
$301 Buy
+26
New +$304 ﹤0.01% 4327
2023
Q1
Sell
-264
Closed -$7K 2117
2022
Q4
$7K Sell
264
-288
-52% -$7.04K ﹤0.01% 3201
2022
Q3
$12K Buy
552
+72
+15% +$1.88K ﹤0.01% 2997
2022
Q2
$13K Buy
480
+93
+24% +$2.67K ﹤0.01% 2972
2022
Q1
$12K Buy
387
+25
+7% +$805 ﹤0.01% 2946
2021
Q4
$12K Buy
362
+299
+475% +$9.67K ﹤0.01% 2874
2021
Q3
$1K Buy
63
+3
+5% +$102 ﹤0.01% 3533
2021
Q2
$2K Buy
60
+3
+5% +$124 ﹤0.01% 3228
2021
Q1
$2K Sell
57
-125
-69% -$5.87K ﹤0.01% 3086
2020
Q4
$8K Buy
182
+25
+16% +$1.04K ﹤0.01% 2294
2020
Q3
$5K Sell
157
-125
-44% -$3.99K ﹤0.01% 2199
2020
Q2
$8K Buy
282
+2
+0.7% +$58 ﹤0.01% 1947
2020
Q1
$8K Hold
280
﹤0.01% 1797
2019
Q4
$9K Hold
280
﹤0.01% 1629
2019
Q3
$10K Sell
280
-3,649
-93% -$139K ﹤0.01% 1407
2019
Q2
$171K Sell
3,929
-127
-3% -$5.43K ﹤0.01% 601
2019
Q1
$173K Buy
4,056
+127
+3% +$5.69K ﹤0.01% 639
2018
Q4
$176K Hold
3,929
﹤0.01% 411
2018
Q3
$269K Buy
+3,929
New +$253K ﹤0.01% 322

Other funds holding AVNS

Rockefeller Capital Management's AVNS Position: Q1 2026 in Review

Rockefeller Capital Management reduced its Avanos Medical (AVNS) stake by 33% in Q1 2026, selling an estimated $175 and leaving 27 shares worth $378. The position accounts for ﹤0.01% of the portfolio, ranked #4579.

Rockefeller Capital Management first reported a position in AVNS in Q3 2018 and has held it in 21 quarters since. The position peaked at $269K in Q3 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Rockefeller Capital Management held 27 shares of Avanos Medical worth $378 as of Q1 2026.
  • Rockefeller Capital Management sold 13 Avanos Medical shares in Q1 2026, an estimated $175.
  • Avanos Medical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4579 holding.
  • Rockefeller Capital Management first reported a position in Avanos Medical in Q3 2018 and has held it in 21 quarters since.
  • Rockefeller Capital Management's Avanos Medical position peaked at $269K in Q3 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.